<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37129609</PMID><DateCompleted><Year>2023</Year><Month>05</Month><Day>17</Day></DateCompleted><DateRevised><Year>2023</Year><Month>05</Month><Day>17</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1437-160X</ISSN><JournalIssue CitedMedium="Internet"><Volume>43</Volume><Issue>7</Issue><PubDate><Year>2023</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Rheumatology international</Title><ISOAbbreviation>Rheumatol Int</ISOAbbreviation></Journal><ArticleTitle>The COVID-19 epidemic curve and vaccine acceptance among patients with rheumatic diseases: an ecological study.</ArticleTitle><Pagination><StartPage>1253</StartPage><EndPage>1264</EndPage><MedlinePgn>1253-1264</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00296-023-05334-1</ELocationID><Abstract><AbstractText>The attitudes toward emerging COVID-19 vaccines have been of great interest worldwide, especially among vulnerable populations such as patients with rheumatic and musculoskeletal diseases (RMDs). The aim of this study was to analyze the relationship between the nationwide number of COVID-19 cases and deaths, and vaccine acceptance or hesitancy of patients with RMDs from four patient care centers in Mexico. Furthermore, we explored differences in acceptance according to specific diagnoses: rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE). This ecological study was a secondary analysis of a cross-sectional study using a validated questionnaire to measure vaccine acceptance. We generated a global Likert scale to evaluate overall attitudes toward the COVID-19 vaccine. We analyzed data from 1336 patients from March to September 2021: 85.13% (1169) were women, with a mean age of 47.87 (SD 14.14) years. The most frequent diagnoses were RA (42.85%, 559) and SLE (27.08%, 393). 635(47.52%) patients were unvaccinated, 253(18.93%) had one dose and 478(35.77%) had two doses. Of all participating patients, 94% were accepting toward the COVID-19 vaccine. Vaccine acceptance remained consistently high throughout the study. However, differences in vaccine acceptance are identified when comparing diagnoses. The peak of the national epidemic curve coincided with an increase in hesitancy among patients with RA. Contrastingly, patients with SLE became more accepting as the epidemic curve peaked. Mexican patients show high acceptance of the COVID-19 vaccine, influenced in part by a patient's specific diagnosis. Furthermore, vaccine acceptance increased mirroring the curve of COVID-19 cases and deaths in the country. This should be taken into consideration when updating recommendations for clinical practice.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gastelum-Strozzi</LastName><ForeName>Alfonso</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-9668-5822</Identifier><AffiliationInfo><Affiliation>Universidad Nacional Aut&#xf3;noma de M&#xe9;xico, Mexico City, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Flores-Alvarado</LastName><ForeName>Diana Elsa</ForeName><Initials>DE</Initials><Identifier Source="ORCID">0000-0003-1181-4977</Identifier><AffiliationInfo><Affiliation>Hospital Universitario Jos&#xe9; Eleuterio Gonz&#xe1;lez, Monterrey, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pascual-Ramos</LastName><ForeName>Virginia</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0002-7368-498X</Identifier><AffiliationInfo><Affiliation>Instituto Nacional de Ciencias M&#xe9;dicas y Nutrici&#xf3;n "Salvador Zubir&#xe1;n", Mexico City, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>&#xc1;lvarez-Hern&#xe1;ndez</LastName><ForeName>Everardo</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0003-2557-5866</Identifier><AffiliationInfo><Affiliation>Hospital General de M&#xe9;xico "Dr. Eduardo Liceaga", Mexico City, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pacheco-Tena</LastName><ForeName>C&#xe9;sar Francisco</ForeName><Initials>CF</Initials><Identifier Source="ORCID">0000-0002-0793-8988</Identifier><AffiliationInfo><Affiliation>Facultad de Medicina y Ciencias Biom&#xe9;dicas, Universidad Aut&#xf3;noma de Chihuahua, Circuito Universitario 31109, Campus Uach II, 31125, Chihuahua, Chih, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guaracha-Bas&#xe1;&#xf1;ez</LastName><ForeName>Guillermo Arturo</ForeName><Initials>GA</Initials><Identifier Source="ORCID">0000-0001-8060-7301</Identifier><AffiliationInfo><Affiliation>Instituto Nacional de Ciencias M&#xe9;dicas y Nutrici&#xf3;n "Salvador Zubir&#xe1;n", Mexico City, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garc&#xed;a</LastName><ForeName>Conrado Garc&#xed;a</ForeName><Initials>CG</Initials><Identifier Source="ORCID">0000-0003-1477-5651</Identifier><AffiliationInfo><Affiliation>Hospital General de M&#xe9;xico "Dr. Eduardo Liceaga", Mexico City, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gonz&#xe1;lez-Ch&#xe1;vez</LastName><ForeName>Susana Aide&#xe9;</ForeName><Initials>SA</Initials><Identifier Source="ORCID">0000-0002-1779-296X</Identifier><AffiliationInfo><Affiliation>Facultad de Medicina y Ciencias Biom&#xe9;dicas, Universidad Aut&#xf3;noma de Chihuahua, Circuito Universitario 31109, Campus Uach II, 31125, Chihuahua, Chih, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moctezuma-R&#xed;os</LastName><ForeName>Jos&#xe9; Francisco</ForeName><Initials>JF</Initials><Identifier Source="ORCID">0000-0002-5339-9620</Identifier><AffiliationInfo><Affiliation>Hospital General de M&#xe9;xico "Dr. Eduardo Liceaga", Mexico City, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Manrique de Lara</LastName><ForeName>Amaranta</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-1531-8770</Identifier><AffiliationInfo><Affiliation>Hospital General de M&#xe9;xico "Dr. Eduardo Liceaga", Mexico City, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Esquivel-Valerio</LastName><ForeName>Jorge Antonio</ForeName><Initials>JA</Initials><Identifier Source="ORCID">0000-0002-3124-0395</Identifier><AffiliationInfo><Affiliation>Hospital Universitario Jos&#xe9; Eleuterio Gonz&#xe1;lez, Monterrey, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Contreras-Y&#xe1;&#xf1;ez</LastName><ForeName>Iraz&#xfa;</ForeName><Initials>I</Initials><Identifier Source="ORCID">0000-0001-6711-2275</Identifier><AffiliationInfo><Affiliation>Instituto Nacional de Ciencias M&#xe9;dicas y Nutrici&#xf3;n "Salvador Zubir&#xe1;n", Mexico City, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Galarza-Delgado</LastName><ForeName>Dionicio &#xc1;ngel</ForeName><Initials>D&#xc1;</Initials><Identifier Source="ORCID">0000-0001-9714-2109</Identifier><AffiliationInfo><Affiliation>Hospital Universitario Jos&#xe9; Eleuterio Gonz&#xe1;lez, Monterrey, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>V&#xe1;zquez-Mellado</LastName><ForeName>Janitzia</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0001-6636-2301</Identifier><AffiliationInfo><Affiliation>Hospital General de M&#xe9;xico "Dr. Eduardo Liceaga", Mexico City, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pel&#xe1;ez-Ballestas</LastName><ForeName>Ingris</ForeName><Initials>I</Initials><Identifier Source="ORCID">0000-0001-5188-7375</Identifier><AffiliationInfo><Affiliation>Hospital General de M&#xe9;xico "Dr. Eduardo Liceaga", Mexico City, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reyes-Cordero</LastName><ForeName>Greta Cristina</ForeName><Initials>GC</Initials><Identifier Source="ORCID">0000-0001-6313-133X</Identifier><AffiliationInfo><Affiliation>Facultad de Medicina y Ciencias Biom&#xe9;dicas, Universidad Aut&#xf3;noma de Chihuahua, Circuito Universitario 31109, Campus Uach II, 31125, Chihuahua, Chih, Mexico. reyesgreta@gmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>05</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Rheumatol Int</MedlineTA><NlmUniqueID>8206885</NlmUniqueID><ISSNLinking>0172-8172</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014612">Vaccines</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Disease" UI="C535686">Rippling muscle disease, 1</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086663" MajorTopicYN="N">COVID-19 Vaccines</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014612" MajorTopicYN="Y">Vaccines</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012216" MajorTopicYN="Y">Rheumatic Diseases</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001172" MajorTopicYN="Y">Arthritis, Rheumatoid</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014611" MajorTopicYN="N">Vaccination</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">COVID-19 vaccine</Keyword><Keyword MajorTopicYN="N">Rheumatic diseases</Keyword><Keyword MajorTopicYN="N">Vaccine acceptance</Keyword><Keyword MajorTopicYN="N">Vaccine hesitancy</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>2</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>4</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>17</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>5</Month><Day>2</Day><Hour>12</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>2</Day><Hour>11</Hour><Minute>4</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37129609</ArticleId><ArticleId IdType="pmc">PMC10153056</ArticleId><ArticleId IdType="doi">10.1007/s00296-023-05334-1</ArticleId><ArticleId IdType="pii">10.1007/s00296-023-05334-1</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Gonz&#xe1;lez-Melado FJ, Di Pietro ML. The vaccine against COVID-19 and institutional trust. Enfermedades Infecc Microbiol Clin Engl Ed. 2020;39:510&#x2013;515. doi: 10.1016/j.eimc.2020.08.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eimc.2020.08.001</ArticleId><ArticleId IdType="pmc">PMC8432885</ArticleId><ArticleId IdType="pubmed">34518151</ArticleId></ArticleIdList></Reference><Reference><Citation>Koch T, Fathi A, Addo MM. The COVID-19 vaccine landscape. Adv Exp Med Biol. 2021;1318:549&#x2013;573. doi: 10.1007/978-3-030-63761-3_31.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-3-030-63761-3_31</ArticleId><ArticleId IdType="pubmed">33973199</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu C, Yi Z, Cai R, Chen R, Thong BY-H, Mu R. Clinical outcomes of COVID-19 in patients with rheumatic diseases: a systematic review and meta-analysis of global data. Autoimmun Rev. 2021;20:102778. doi: 10.1016/j.autrev.2021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2021</ArticleId><ArticleId IdType="pmc">PMC7889462</ArticleId><ArticleId IdType="pubmed">33609804</ArticleId></ArticleIdList></Reference><Reference><Citation>Strangfeld A, Sch&#xe4;fer M, Gianfrancesco MA, Lawson-Tovey S, Liew JW, Ljung L, Mateus EF, Richez C, Santos MJ, Schmajuk G, Scir&#xe8; CA, et al. Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry. Ann Rheum Dis. 2021;80:930&#x2013;942. doi: 10.1136/annrheumdis-2020-219498.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2020-219498</ArticleId><ArticleId IdType="pmc">PMC7843211</ArticleId><ArticleId IdType="pubmed">33504483</ArticleId></ArticleIdList></Reference><Reference><Citation>Bijlsma JW, EULAR COVID-19 Task Force EULAR 2021 updated viewpoints on SARS-CoV-2 vaccination in patients with RMDs: a guidance to answer patients' questions. Ann Rheum Dis. 2022;81:786&#x2013;788. doi: 10.1136/annrheumdis-2021-221965.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2021-221965</ArticleId><ArticleId IdType="pubmed">35121591</ArticleId></ArticleIdList></Reference><Reference><Citation>PAHO/WHO (2019) Ten threats to global health in 2019. https://www.who.int/news-room/spotlight/ten-threats-to-global-health-in-2019. Accessed 21 June 2022</Citation></Reference><Reference><Citation>MacDonald NE, SAGE Working Group on Vaccine Hesitancy Vaccine hesitancy: definition, scope and determinants. Vaccine. 2015;33:4161&#x2013;4164. doi: 10.1016/j.vaccine.2015.04.036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2015.04.036</ArticleId><ArticleId IdType="pubmed">25896383</ArticleId></ArticleIdList></Reference><Reference><Citation>Carnalla M, Basto-Abreu A, Stern D, Bautista-Arredondo S, Shamah-Levy T, Alpuche-Aranda CM, Rivera-Dommarco J, Barrientos-Guti&#xe9;rrez T. Acceptance, refusal and hesitancy of Covid-19 vaccination in Mexico: Ensanut 2020 Covid-19. Salud Publica Mex. 2021;63:598&#x2013;606. doi: 10.21149/12696.</Citation><ArticleIdList><ArticleId IdType="doi">10.21149/12696</ArticleId><ArticleId IdType="pubmed">35099875</ArticleId></ArticleIdList></Reference><Reference><Citation>Lazarus JV, Ratzan SC, Palayew A, Gostin LO, Larson HJ, Rabin K, Kimball S, El-Mohandes A. A global survey of potential acceptance of a COVID-19 vaccine. Nat Med. 2021;27:225&#x2013;228. doi: 10.1038/s41591-020-1124-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-1124-9</ArticleId><ArticleId IdType="pmc">PMC7573523</ArticleId><ArticleId IdType="pubmed">33082575</ArticleId></ArticleIdList></Reference><Reference><Citation>Guaracha-Basa&#xf1;ez GA, Contreras-Y&#xe1;&#xf1;ez I, &#xc1;lvarez-Hern&#xe1;ndez E, Reyes-Cordero G, Flores-Alvarado DE, Gonz&#xe1;lez-Ch&#xe1;vez SA, Galarza-Delgado D&#xc1;, Mart&#xed;nez-Leyva PR, Moctezuma-R&#xed;os JF, Garc&#xed;a-Garc&#xed;a C, Medrano-Ram&#xed;rez G, Gastelum-Strozzi A, Pacheco-Tena C, Pel&#xe1;ez-Ballestas I, Pascual-Ramos V. Factors associated to COVID-19 vaccine acceptance in Mexican patients with rheumatic diseases: A cross-sectional and multicenter study. Hum Vaccines Immunother. 2022;18:2049131. doi: 10.1080/21645515.2022.2049131.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21645515.2022.2049131</ArticleId><ArticleId IdType="pmc">PMC9196644</ArticleId><ArticleId IdType="pubmed">35389817</ArticleId></ArticleIdList></Reference><Reference><Citation>Tedeschi SK, Ellrodt J, Stratton J, Santacroce L, Chandler PD, Gravallese EM, Solomon DH. Acceptability of vaccines against preventable infections including Coronavirus Disease 2019 among patients with Rheumatic Disease. ACR Open Rheumatol. 2022;4:3&#x2013;7. doi: 10.1002/acr2.11351.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acr2.11351</ArticleId><ArticleId IdType="pmc">PMC8652709</ArticleId><ArticleId IdType="pubmed">34613668</ArticleId></ArticleIdList></Reference><Reference><Citation>Priori R, Pellegrino G, Colafrancesco S, Alessandri C, Ceccarelli F, Di Franco M, Riccieri V, Scrivo R, SiliScavalli A, Spinelli FR, Conti F. SARS-CoV-2 vaccine hesitancy among patients with rheumatic and musculoskeletal diseases: a message for rheumatologists. Ann Rheum Dis. 2021;80:953&#x2013;954. doi: 10.1136/annrheumdis-2021-220059.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2021-220059</ArticleId><ArticleId IdType="pubmed">33622689</ArticleId></ArticleIdList></Reference><Reference><Citation>Ko T, Dendle C, Woolley I, Morand E, Antony A. SARS-COV-2 vaccine acceptance in patients with rheumatic diseases: a cross-sectional study. Hum Vaccines Immunother. 2021;17:4048&#x2013;4056. doi: 10.1080/21645515.2021.1958611.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21645515.2021.1958611</ArticleId><ArticleId IdType="pmc">PMC8828082</ArticleId><ArticleId IdType="pubmed">34357827</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaur P, Agrawat H, Shukla A. COVID-19 vaccine hesitancy in patients with systemic autoimmune rheumatic disease: an interview-based survey. Rheumatol Int. 2021;41:1601&#x2013;1605. doi: 10.1007/s00296-021-04938-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00296-021-04938-9</ArticleId><ArticleId IdType="pmc">PMC8249840</ArticleId><ArticleId IdType="pubmed">34213580</ArticleId></ArticleIdList></Reference><Reference><Citation>El Kibbi L, Metawee M, Hmamouchi I, Abdulateef N, Halabi H, Eissa M, El Rakawi M, Masri B, Abutiban F, Hamdi W, Adnan A, Najm AA, Felten R, Arnaud L, Ziad&#xe9; N. Acceptability of the COVID-19 vaccine among patients with chronic rheumatic diseases and health-care professionals: a cross-sectional study in 19 Arab countries. Lancet Rheumatol. 2022;4:e160&#x2013;e163. doi: 10.1016/S2665-9913(21)00368-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2665-9913(21)00368-4</ArticleId><ArticleId IdType="pmc">PMC8668191</ArticleId><ArticleId IdType="pubmed">34927089</ArticleId></ArticleIdList></Reference><Reference><Citation>Yurttas B, Poyraz BC, Sut N, Ozdede A, Oztas M, U&#x11f;urlu S, Tabak F, Hamuryudan V, Seyahi E. Willingness to get the COVID-19 vaccine among patients with rheumatic diseases, healthcare workers and general population in Turkey: a web-based survey. Rheumatol Int. 2021;41:1105&#x2013;1114. doi: 10.1007/s00296-021-04841-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00296-021-04841-3</ArticleId><ArticleId IdType="pmc">PMC8006103</ArticleId><ArticleId IdType="pubmed">33779780</ArticleId></ArticleIdList></Reference><Reference><Citation>Morgenstern H. Ecologic studies in epidemiology: concepts, principles, and methods. Annu Rev Public Health. 1995;16:61&#x2013;81. doi: 10.1146/annurev.pu.16.050195.000425.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.pu.16.050195.000425</ArticleId><ArticleId IdType="pubmed">7639884</ArticleId></ArticleIdList></Reference><Reference><Citation>Guaracha-Bas&#xe1;&#xf1;ez G, Contreras-Y&#xe1;&#xf1;ez I, &#xc1;lvarez-Hern&#xe1;ndez E, Rom&#xe1;n-Montes CM, Meza-L&#xf3;pez Y, Olgu&#xed;n G, Morales-Graciano MJ, Valverde-Hern&#xe1;ndez SS, Pel&#xe1;ez-Ballestas I, Pascual-Ramos V. COVID-19 vaccine hesitancy among Mexican outpatients with rheumatic diseases. Hum Vaccines Immunother. 2021;17:5038&#x2013;5047. doi: 10.1080/21645515.2021.2003649.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21645515.2021.2003649</ArticleId><ArticleId IdType="pmc">PMC8903992</ArticleId><ArticleId IdType="pubmed">34856876</ArticleId></ArticleIdList></Reference><Reference><Citation>Gastelum-Strozzi A, Pel&#xe1;ez-Ballestas I (2021) BIOCOMLAB&#x2014;SSEM. http://www.biocomlab.com/apps/SSEM.html. Accessed 21 June 2022.</Citation></Reference><Reference><Citation>Freeman D, Loe BS, Chadwick A, Vaccari C, Waite F, Rosebrock L, Jenner L, Petit A, Lewandowsky S, Vanderslott S, Innocenti S, Larkin M, Giubilini A, Yu LM, McShane H, Pollard AJ, Lambe S. COVID-19 vaccine hesitancy in the UK: the Oxford coronavirus explanations, attitudes, and narratives survey (Oceans) II. Psychol Med. 2020;11:1&#x2013;15. doi: 10.1017/S0033291720005188.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0033291720005188</ArticleId><ArticleId IdType="pmc">PMC7804077</ArticleId><ArticleId IdType="pubmed">33305716</ArticleId></ArticleIdList></Reference><Reference><Citation>Heiberger Richard M, Naomi Robbins B. Design of diverging stacked bar charts for likert scales and other applications. J Stat Softw. 2014;57:1&#x2013;32. doi: 10.18637/jss.v057.i05.</Citation><ArticleIdList><ArticleId IdType="doi">10.18637/jss.v057.i05</ArticleId><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Secretar&#xed;a de Salud (2022) Datos Abiertos Direcci&#xf3;n General de Epidemiolog&#xed;a. https://www.gob.mx/salud/documentos/datos-abiertos-152127. Accessed 30 September 2021.</Citation></Reference><Reference><Citation>Mohanasundaram K, Santhanam S, Natarajan R, Murugesan H, Nambi T, Chilikuri B, Nallasivan S. Covid-19 vaccination in autoimmune rheumatic diseases: a multi-center survey from southern India. Int J Rheum Dis. 2022;25:1046&#x2013;1052. doi: 10.1111/1756-185X.14378.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1756-185X.14378</ArticleId><ArticleId IdType="pmc">PMC9349850</ArticleId><ArticleId IdType="pubmed">35773944</ArticleId></ArticleIdList></Reference><Reference><Citation>Santos JI. La vacunaci&#xf3;n en M&#xe9;xico en el marco de las &#x201c;d&#xe9;cadas de las vacunas&#x201d;: logros y desaf&#xed;os. Gac M&#xe9;dica M&#xe9;xico. 2014;150:180&#x2013;188.</Citation><ArticleIdList><ArticleId IdType="pubmed">24604001</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh JA, Richards JS, Chang E, Joseph A, Ng B. Management of rheumatic diseases during the COVID-19 pandemic: a national veterans affairs survey of rheumatologists. Arthritis Care Res. 2021;73:998&#x2013;1003. doi: 10.1002/acr.24487.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acr.24487</ArticleId><ArticleId IdType="pmc">PMC7675431</ArticleId><ArticleId IdType="pubmed">33058485</ArticleId></ArticleIdList></Reference><Reference><Citation>Hammam N, Tharwat S, Shereef RRE, Elsaman AM, Khalil NM, Fathi HM, Salem MN, El-Saadany HM, Samy N, El-Bahnasawy AS, Abdel-Fattah YH, Amer MA, ElShebini E, El-Shanawany AT, El-Hammady DH, Noor RA, ElKhalifa M, Ismail F, Fawzy RM, El-Najjar AR, Selim ZI, Abaza NM. Rheumatology university faculty opinion on coronavirus disease-19 (COVID-19) vaccines: the vaXurvey study from Egypt. Rheumatol Int. 2021;41:1607&#x2013;1616. doi: 10.1007/s00296-021-04941-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00296-021-04941-0</ArticleId><ArticleId IdType="pmc">PMC8269986</ArticleId><ArticleId IdType="pubmed">34244818</ArticleId></ArticleIdList></Reference><Reference><Citation>Cardiel MH, D&#xed;az-Borj&#xf3;n A, del Mercado Espinosa MV, G&#xe1;mez-Nava JI, BarileFabris LA, Tena CP, Silveira Torre LH, Ramos VP, Goycochea Robles MV, Aguilar Arreola JE, D&#xed;az VG, Nemegyei J&#xc1;, del Carmen Gonz&#xe1;lez-L&#xf3;pez L, et al. Actualizaci&#xf3;n de la Gu&#xed;a Mexicana para el Tratamiento Farmacol&#xf3;gico de la Artritis Reumatoide del Colegio Mexicano de Reumatolog&#xed;a. Reumatol Cl&#xed;nica. 2014;10:227&#x2013;240. doi: 10.1016/j.reuma.2013.10.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.reuma.2013.10.006</ArticleId></ArticleIdList></Reference><Reference><Citation>Colmenares-Roa T, ManriquedeLara A, Pascual Ramos V, MOCTEZUMA RIOS J, Contreras-Iba&#xf1;ez I, Alvarez-Hernandez E, Guaracha Basa&#xf1;ez G, Meza-L&#xf3;pezyOlguin G, Pelaez-Ballestas I (2022) Sociocultural and Moral Factors Influencing the Decision to Vaccinate Among Rheumatic Patients: A Qualitative Study [abstract]. Arthritis Rheumatol 74 (suppl 9). Accessed 9 April 2023.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10152007</ArticleId><ArticleId IdType="pubmed">37129776</ArticleId></ArticleIdList></Reference><Reference><Citation>Sen P, Naveen R, Houshmand N, Moghadam Kia S, Joshi M, Saha S, Jagtap K, Agarwal V, Nune A, Nikiphorou E, Tan AL, Shinjo SK, Ziade N, Velikova T, Milchert M, Parodis I, Edgar Gracia-Ramos A, Cavagna L, Kuwana M, Knitza J, Makol A, Patel A, Pauling JD, Wincup C, Barman B, Zamora Tehozol EA, Rojas Serrano J, La Torre IG, Colunga-Pedraza IJ, Merayo-Chalico J, Chibuzo OC, Katchamart W, et al. Vaccine hesitancy decreases, long term concerns remain in myositis, rheumatic disease patients: a comparative analysis of the COVAD surveys. Rheumatology. 2023;3:kead057. doi: 10.1093/rheumatology/kead057.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/kead057</ArticleId><ArticleId IdType="pubmed">36734536</ArticleId></ArticleIdList></Reference><Reference><Citation>Felten R, Dubois M, Ugarte-Gil MF, Chaudier A, Kawka L, Bergier H, Costecalde C, Pijnenburg L, Fort J, Chatelus E, Sordet C, Javier RM, Gottenberg JE, Sibilia J, Fuentes-Silva Y, Arnaud L. Vaccination against COVID-19: expectations and concerns of patients with autoimmune and rheumatic diseases. Lancet Rheumatol. 2021;3:e243&#x2013;e245. doi: 10.1016/S2665-9913(21)00039-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2665-9913(21)00039-4</ArticleId><ArticleId IdType="pmc">PMC7906671</ArticleId><ArticleId IdType="pubmed">33655219</ArticleId></ArticleIdList></Reference><Reference><Citation>Fathi HM, Gazzar IIE, Elazeem MIA, AboulKheir E, Gamal NM, Ismail F, Shereef RRE, Tharwat S, Elwan S, Samy N, Baki NA, Elsaid NY, El-Bahnasawy AS, Moshrif A, Fattah YA, Amer MA, Ibrahim ME, Khalil NM, El-Dessouki S, Abaza N, El-Shanawany AT, Mohamed EF, El-Ghobashy N, Ayoub N, Hammam O, Fawzy S, Sayed S, Gheita TA, Hammam N. Rheumatologists&#x2019; knowledge and perception of COVID-19 and related vaccines: the vaXurvey2 online survey. Rheumatol Int. 2022;42:989&#x2013;998. doi: 10.1007/s00296-022-05130-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00296-022-05130-3</ArticleId><ArticleId IdType="pmc">PMC9012992</ArticleId><ArticleId IdType="pubmed">35429291</ArticleId></ArticleIdList></Reference><Reference><Citation>Machado PM, Lawson-Tovey S, Strangfeld A, Mateus EF, Hyrich KL, Gossec L, Carmona L, Rodrigues A, Raffeiner B, Duarte C, Hachulla E, Veillard E, Strakova E, Burmester GR, Yard&#x131;mc&#x131; GK, Gomez-Puerta JA, Zepa J, Kearsley-Fleet L, Trefond L, Cunha M, Mosca M, Cornalba M, Soubrier M, Roux N, et al. Safety of vaccination against SARS-CoV-2 in people with rheumatic and musculoskeletal diseases: results from the EULAR Coronavirus Vaccine (COVAX) physician-reported registry. Ann Rheum Dis. 2022;81:695&#x2013;709. doi: 10.1136/annrheumdis-2021-221490.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2021-221490</ArticleId><ArticleId IdType="pubmed">34972811</ArticleId></ArticleIdList></Reference><Reference><Citation>Landew&#xe9; RBM, Kroon FPB, Alunno A, Najm A, Bijlsma JW, Burmester GR, Caporali R, Combe B, Conway R, Curtis JR, Elkayam O, Gossec L, Heijstek MW, Haupt L, Iagnocco A, Isaacs JD, Juh&#xe1;sz I&#xc1;, Makri S, Mariette X, et al. EULAR recommendations for the management and vaccination of people with rheumatic and musculoskeletal diseases in the context of SARS-CoV-2: the November 2021 update. Ann Rheum Dis. 2022;81:1628&#x2013;1639. doi: 10.1136/annrheumdis-2021-222006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2021-222006</ArticleId><ArticleId IdType="pubmed">35197264</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>